Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining 0.90% today. In the last week its performance is 0.71%, and 3.67% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 47.55, so today’s gain of 0.90% is a significant step towards its target price. The GAP today is therefore 0.58%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 106.86 B, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 9.30%.
At the current price of 43.82, it has a dividend yield of 4.45%, and its target price is 47.55. This is with a profit margin of 5.80%, and total debt/equity of 10.7. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 50.25, as well as a forward P/E of 15.34.
With a current EPS of 0.87, and a forecasted EPS growth for next year at 1.24%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at -28.90%. For the next five years EPS growth is projected to be 13.10%.
Performance for the year is 8.01%. Since its IPO date on 07/09/1986, the total performance to date is 13.79%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 1920459, while its average volume is 2980.43. Whilst the total gain today was 0.90%, it did have a day high of -1.61%.
Volatility for this week has been at 0.76%, and 0.83% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 17.80%, while the 52-week-high has reached -3.86%.
Looking at its return of investments, which is 8.60%, and its return on assets is 2.90%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 12.40%. With a sales growth of 18.50% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 8.52, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 3.84, and the P/S is 2.88, along with a P/B of 48.69. Meanwhile it has a p/cash of 18.23.